Andra Ap Fonden Viatris Inc Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

A detailed history of Andra Ap Fonden transactions in Viatris Inc stock. As of the latest transaction made, Andra Ap Fonden holds 421,309 shares of VTRS stock, worth $5.27 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

421,309

Previous 823,809 48.86%

Holding current value

$5.27 Million

Previous $8.76 Million 44.15%

% of portfolio

0.07%

Previous 0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.32 - $12.13 $4.15 Million - $4.88 Million	-402,500 Reduced 48.86%	421,309 $4.89 Million
Q2 2024 Aug 07, 2024	BUY	$10.05 - $12.02 $76,339 - $91,303	7,596 Added 0.93%	823,809 $8.76 Million
Q1 2024 May 13, 2024	BUY	$11.27 - $13.53 $1.91 Million - $2.29 Million	169,604 Added 26.23%	816,213 $9.75 Million
Q4 2023 Feb 15, 2024	BUY	$8.77 - $10.85 $803,332 - $993,860	91,600 Added 16.5%	646,609 $7 Million
Q3 2023 Nov 09, 2023	BUY	$9.59 - $11.35 $68,089 - $80,585	7,100 Added 1.3%	555,009 $5.47 Million
Q2 2023 Aug 09, 2023	BUY	$9.02 - $10.29 $635,910 - $725,444	70,500 Added 14.77%	547,909 $5.47 Million
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $1.91 Million - $2.55 Million	207,700 Added 77.01%	477,409 $4.59 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $2.35 Million - $3.12 Million	269,709 New	269,709 $3 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $1.78 Million - $2.22 Million	-137,509 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $1.71 Million - $2.34 Million	-126,000 Reduced 47.82%	137,509 $1.92 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $3.77 Million - $4.94 Million	263,509 New	263,509 $4.94 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account